Position in A
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$8,392,199
-$7,431,188 QoQ
Shares Held
63,180
-54.5% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#234
of 1,119 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Derivatives in A
reported options exposure · as of Mar 31, 2023CallValue
$3,347,828
CallShares
24,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $239,574,818 across 21 Diagnostics & Research names. A ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
193,340 | $96,932,942 | |
| 2 | GRAL |
GRAIL, Inc.
|
724,000 | $49,427,480 | |
| 3 | QGEN |
Qiagen N.V.
|
618,798 | $24,195,001 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
84,902 | $16,404,764 | |
| 5 | CSTL |
Castle Biosciences Inc
|
647,391 | $15,440,275 | |
| 6 | A |
Agilent Technologies, Inc.
This page
|
63,180 | $8,392,199 | |
| 7 | GH |
Guardant Health, Inc.
|
35,629 | $5,345,418 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
18,270 | $4,143,453 |
All Filings in A
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,392,199 | 63,180 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $15,823,387 | 138,826 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $16,435,078 | 120,784 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $10,754,574 | 83,791 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,413,539 | 79,769 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $18,565,076 | 158,703 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $16,816,143 | 125,176 | Shares | Defined | 2025-02-27 | |
| 2024-09-30 | $6,079,959 | 40,948 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,342,632 | 56,643 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,300,874 | 43,302 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $639,538 | 4,600 | Shares | Defined | 2024-05-06 | |
| 2023-09-30 | $3,928,348 | 35,131 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,350,522 | 52,811 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,347,828 | 24,200 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $13,339,434 | 96,425 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,016,944 | 20,160 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||